Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

NASDAQ:DYN

Overview | Financials
Company Name Dyne Therapeutics, Inc.
Symbol DYN
Currency USD
Price 28.48
Market Cap 2,859,420,480
Dividend Yield 0%
52-week-range 8.044 - 47.45
Industry Biotechnology
Sector Healthcare
CEO Mr. Joshua T. Brumm
Website https://www.dyne-tx.com

An error occurred while fetching data.

About Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and

Related Stocks

Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc.

LXRX

1.27 USD

AlloVir, Inc. logo

AlloVir, Inc.

ALVR

0.619 USD

AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc.

ANTX

1.1 USD

4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc.

FDMT

8.12 USD

Financials

Numbers are in millions USD

Numbers are in millions USD